$LMNX on NASDAQ
July 12, 2021
Middlesex Water Set to Join S&P SmallCap 600
May 20, 2021
Luminex Corporation Declares Second Quarter Cash Dividend
April 12, 2021
DiaSorin to acquire Luminex Corporation for USD 37.00 per share or approximately USD 1.8 billion
March 10, 2021
Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization
March 09, 2021
Luminex Corporation to Participate at the 2021 Barclays Global Healthcare Conference
March 04, 2021
Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG® Respiratory Panel Test Including SARS-CoV-2
February 19, 2021
Luminex Receives BARDA Funding to Support Development and Validation of Test Combining SARS-CoV-2 and Flu/RSV Respiratory Panel
February 08, 2021
Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results
February 08, 2021
Luminex Corporation Declares First Quarter Cash Dividend
January 27, 2021
Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 8, 2021
January 13, 2021
Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference
January 12, 2021
Luminex Corporation Pre-Release of 4th Quarter 2020 Revenue
December 16, 2020
Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference
December 07, 2020
Luminex Corporation Declares Fourth Quarter Cash Dividend
November 05, 2020
Luminex Corporation Reports Strong Third Quarter 2020 Results
October 22, 2020
Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2020
October 07, 2020
Luminex Corporation Pre-Release of 3rd Quarter 2020 Revenue
September 24, 2020
Luminex Receives BARDA Award to Support 510(k) Filing for NxTAG Respiratory Pathogen Panel That Includes SARS-CoV-2
September 23, 2020
Luminex Receives BARDA Award to Support Enhancement of COVID-19 Multiplex Antibody Test
September 15, 2020
Luminex Corporation Declares Third Quarter Cash Dividend
August 04, 2020
Luminex Corporation Announces Departure of G. Walter Loewenbaum from Its Board of Directors
August 04, 2020
Luminex Corporation Reports Second Quarter 2020 Results
July 22, 2020
Luminex Files for Emergency Use Authorization for Expanded NxTAG Respiratory Panel Test Including SARS-CoV-2
July 20, 2020
Luminex Corporation Second Quarter Earnings Release Rescheduled for August 4, 2020
July 20, 2020
Luminex Receives FDA Emergency Use Authorization for COVID-19 Antibody Test
July 08, 2020
Luminex Corporation Pre-Release of 2nd Quarter 2020 Revenue
July 01, 2020
Luminex Delivers xMAP® INTELLIFLEX Systems to Life Science Research Partners
June 29, 2020
Luminex Submits Emergency Use Authorization Request to U.S. FDA for COVID-19 Antibody Test
May 22, 2020
Luminex Corporation Declares Second Quarter Cash Dividend
May 08, 2020
Luminex Corporation Announces Pricing Of Offering Of $260 Million Of 3.00% Convertible Senior Notes Due 2025
May 04, 2020
Luminex Corporation Reports First Quarter 2020 Results
April 22, 2020
Luminex Corporation First Quarter Earnings Release Rescheduled for May 4, 2020
April 06, 2020
Luminex Corporation Pre-Release of 1st Quarter Revenue
April 06, 2020
Luminex Receives FDA Emergency Use Authorization for ARIES® SARS-CoV-2 Assay to Detect Virus Responsible for COVID-19 Disease
March 31, 2020
Luminex Receives BARDA Contract to Support Development of Second, Rapid SARS-CoV-2 Test
March 27, 2020
Luminex Receives FDA Emergency Use Authorization for NxTAG® CoV Extended Panel to Detect the SARS-CoV-2 Virus that Causes COVID-19 Disease
March 13, 2020
Luminex Provides Update on SARS-CoV-2 Validation Testing Efforts
March 04, 2020
Luminex Provides Updates on Critical Efforts Related to Novel Coronavirus
February 24, 2020
Luminex Corporation Submits VERIGENE® II Respiratory Flex Assay for FDA Clearance
February 18, 2020
Luminex Corporation Declares First Quarter Cash Dividend
February 13, 2020
Luminex Corporation to Participate At Upcoming Healthcare Investor Conferences in March 2020
February 10, 2020
Luminex Corporation Reports Fourth Quarter and Full-Year 2019 Results
January 23, 2020
Luminex Corporation To Release Fourth Quarter and Full-Year 2019 Results After Market Close On February 10, 2020
January 12, 2020
Luminex Corporation Announces 2019 Highlights and 2020 Guidance; Company to Present at 38th Annual J.P. Morgan Healthcare Conference
December 06, 2019
Luminex Corporation Declares Fourth Quarter Cash Dividend
November 25, 2019
Luminex Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference on December 4, 2019
November 04, 2019
Luminex Corporation Reports Third Quarter 2019 Results and Submission of VERIGENE II Gastrointestinal Flex Assay to the FDA
October 25, 2019
Luminex Corporation To Release Third Quarter 2019 Results After Market Close On November 4, 2019
October 01, 2019
Luminex Receives FDA 510(k) Clearance for the ARIES® MRSA Assay
September 26, 2019
Luminex Corporation to Present at the Cantor Global Healthcare Conference on October 2, 2019
- No Recent Filings Found.
